See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2019_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 152,877,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 205,184,000 |
| 2 | PropertyPlantAndEquipmentNet | 38,090,000 |
| 3 | remainder_Assets | 34,453,000 |
| 4 | LiabilitiesCurrent | 165,549,000 |
| 5 | LiabilitiesNoncurrent | 67,792,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 68,759,099 |
| 8 | SellingGeneralAndAdministrativeExpense | 67,488,478 |
| 9 | ResearchAndDevelopmentExpense | 14,088,524 |
| 10 | remainder_Expenses | 32,713,853 |
| 11 | remainder_Revenues | 286,767,568 |
| 12 | remainder_NetIncome | -15,119,960 |
| 13 | remainder_ComprehensiveNetIncome | -379,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 430,604,000 |
| 1 | Liabilities | 233,341,000 |
| 2 | Expenses | 183,049,954 |
| 3 | Revenues | 286,767,568 |
| 4 | StockholdersEquity | 197,263,000 |
| 5 | NetIncome | 88,597,654 |
| 6 | ComprehensiveNetIncome | 88,408,154 |
| 7 | BaseVar | 574,630,741 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.56 |
| 9 | EconomicCapitalRatio | 2.72 |
Edgar->Model Mapping
Feature Distribution
Change over Time
